We have measured how a low concentration of nitrous oxide affected respiratory sensation and ventilation. Severe dyspnoea was induced in nine normal subjects by a combination of hypercapnia and inspiratory elastic load (50 cm H 2 O litre -1 ). Subjects were asked to rate their sensation of respiratory discomfort using a visual analogue scale (VAS) while breathing either 20% nitrous oxide or 20% nitrogen gas mixture. We compared the effects of each gas mixture on respiratory sensation and ventilation using steady-state values of ventilatory variables and VAS scores obtained before, during and after inhalation of each gas mixture. Inhalation of 20% nitrous oxide reduced the sensation of respiratory discomfort from a median VAS score of 6.5 (range 5.0-8.1) before inhalation to 3.6 (2.4-5.9) during inhalation (PϽ0.05). There was no significant change in minute ventilation but tidal volume increased during inhalation of 20% nitrous oxide (PϽ0.05) while respiratory frequency decreased (PϽ0.05). Inhalation of 20% nitrogen did not alter VAS scores or ventilatory variables. We found that a low concentration of nitrous oxide greatly alleviated the intensity of dyspnoea without changing respiratory load compensation.
Dyspnoea is a serious symptom that is often difficult to treat. Although different treatments are available for patients with intractable dyspnoea, opioids are likely to be an essential component of therapy. 1 Nitrous oxide is a weak anaesthetic that can produce moderate analgesia and light sedation at concentration of 6-26%. 2 In volunteers, the analgesic potency of 20% nitrous oxide is equivalent to 15 mg of morphine. 3 Unlike opioids, no serious side effects have been reported with low concentrations of nitrous oxide. Because of the absence of serious side effects, a low concentration of nitrous oxide could be used as an alternative to opioids to relieve dyspnoea. It is not known if nitrous oxide relieves dyspnoea. We set out to assess the efficacy of a low concentration of nitrous oxide in experimental dyspnoea. Respiratory compensation during severe respiratory loading with low concentration nitrous oxide breathing was also assessed.
Subjects and methods
We studied eight male and two female volunteers, aged 25-39 yr. All were in good health and were free of respiratory, cardiovascular or neuromuscular disorders. The study was approved by the Institutional Ethics Committee and each © British Journal of Anaesthesia subject gave informed consent. None of the subjects knew the purpose of the study.
Each subject was seated during the experiment and breathed through an experimental apparatus containing a face mask, pneumotachograph (CP-100, Allied Health Care Product Inc., St Louis, MO, USA) and a one-way valve system. The experimental apparatus had a resistance of 5 cm H 2 O litre -1 s -1 at a flow rate of 0.5 litre s -1 and the total apparatus deadspace was 150 ml.
In order to induce dyspnoea, external respiratory loads consisting of an additional deadspace (a plastic tube of 350 ml in capacity) and an elastic load (a 20-litre rigid glass bottle with a vent valve) were added to the experimental apparatus (Fig. 1) . The vent valve of the elastic load was closed throughout each inspiration and opened promptly during expiration to replenish the load with fresh gas and maintain the load constant from breath to breath. Closing and opening of the valve was affected by a solenoid triggered by the flow signal of the pneumotachograph. The distal limb of the vent valve was connected to a T-piece system supplied with fresh gas of 100% oxygen, 20% nitrous oxide with 80% oxygen or 20% nitrogen with 80% oxygen. The magnitude of the elastic load was 50 cm H 2 O litre -1 . Ventilatory airflow was measured through the pneumotachograph and tidal volume (VT) was obtained by electrical integration of the inspired flow signal. Mask pressure (Pmask) was measured with a pressure transducer (Transpac IV, Abbott Critical Care Systems, Chicago, IL, USA). Endexpiratory carbon dioxide concentration (PEЈ CO 2 ) and nitrous oxide concentration were measured via a port in the face mask with an infrared carbon dioxide analyser with automatic correction for nitrous oxide (Aika MEL RAS-41; Tokyo, Japan) and an anaesthetic gas monitor (Brüel and Kjaer type 1304; Denmark), respectively. Volume and gas calibrations were performed using a 1-litre syringe with three different gas mixtures (5% carbon dioxide in oxygen, 8% carbon dioxide in oxygen, and 8% carbon dioxide with 20% nitrous oxide in oxygen) from calibrating tanks.
During the experiment, the subject was asked to rate the intensity of the sensation of respiratory discomfort using a visual analogue scale (VAS). The analogue scale consisted of a horizontal 20-cm line on which there were 10 equally spaced markers. Subjects could control the position of the knob of a linear potentiometer along this line ranging from 0 to 10. The numerical value of 0 was given for the sensation of 'not at all unpleasant' and 10 for the sensation of 'intolerable'. Respiratory discomfort was defined as 'an unpleasant urge to breathe'. No further clarification or definitions were given, but subjects were asked to avoid rating non-respiratory sensations such as headache or lassitude.
Airflow, VT, Pmask, PEЈ CO 2 and VAS score were recorded on a thermal array recorder (Omniace RT3424, NEC, Tokyo).
Before starting the study, a dummy run was performed to familiarize the subject with the apparatus, the sensation of breathing against the added load and the use of the VAS. The main study was conducted 10 min after this. The study plan is outlined below.
The subject breathed 100% oxygen through the face mask and pneumotachograph for at least 5 min, and breathing was recorded for 3-4 min (unloaded breathing). The subject then had two 20-min trials of loaded breathing. A 10-min rest period separated the two trials. In each of the trials, after application of the elastic load and deadspace, 5 min were allowed for establishment of steady respiratory state and respiratory sensation while 100% oxygen fresh gas was replenishing the load (baseline period). Then the fresh gas was changed to either a gas mixture of 20% nitrous oxide in oxygen or 20% nitrogen in oxygen, and the subject continued to breathe for 10 min (test period) while rating the magnitude of respiratory discomfort using the VAS score. The fresh gas was changed again to 100% oxygen and the subject continued to breathe for another 5 min (recovery period). The order of administration of the gas mixture of 20% nitrous oxide in oxygen and 20% nitrogen in oxygen was randomized. At the end of the experiment, subjects were questioned about dyspnoea and other sensations.
The effects of nitrous oxide on respiratory sensation and ventilation were evaluated by comparing the values of the ventilatory variables and VAS scores obtained from measurements at the last 5 min during the baseline and test periods. Inspiratory time (TI) was defined as the time between the onset and termination of inspiratory flow, and expiratory time (TE) as the remainder of the respiratory cycle. Pmax was defined as the maximum negative pressure developed in the mask during inspiration. Minute ventilation (V I) was calculated as the product of VT and respiratory frequency (f).
Statistical analysis was performed using Friedman's repeated measures ANOVA on ranks, followed by Dunnet's test. Data are expressed as median [range] . PϽ0.05 was taken as significant.
Results
Nine of 10 subjects tolerated loading and inhalation of nitrous oxide, and completed the study. However, one subject could not tolerate inhalation of nitrous oxide because of worsening dyspnoea immediately after the start of nitrous oxide inhalation, and data from this subject were excluded.
Breathing patterns observed in nine subjects during unloaded breathing are summarized in Table 1 . Immediately after application of the elastic load and deadspace, there were changes in VT and respiratory frequency (f) with a concomitant increase in VAS score. These changes gradually stabilized within 4 min, and thereafter breathing patterns and VAS scores remained nearly steady. The steady breathing patterns during loaded breathing were characterized by a rapid breathing with shortening of both inspiratory (TI) and expiratory (TE) times (Table 2 , baseline period).
In most subjects, inhalation of nitrous oxide caused a gradual increase in VT and decrease in f, with a concomitant decrease in VAS scores, and these changes stabilized within 5 min after the start of nitrous oxide inhalation during which end-expiratory nitrous oxide concentration reached a steady state level of 17-18%. Thereafter, breathing patterns and VAS scores remained constant (Fig. 2) . After stopping nitrous oxide, breathing patterns and VAS scores gradually returned to pre-nitrous oxide inhalation levels. Table 2 summarizes changes in respiratory variables during the baseline period, steady-state test period and recovery period. Inhalation of 20% nitrogen caused no changes in respiratory variables. In contrast, inhalation of 20% nitrous oxide caused a significant increase in VT and a significant decrease in f. The decrease in f was caused by prolongation of TE whereas there was no significant change in TI. There was no significant change in minute ventilation, both during inhalation of 20% nitrous oxide and during inhalation of 20% nitrogen. Neither VT/TI nor the maximum Figure 3 shows changes in VAS scores during 20% nitrogen and 20% nitrous oxide inhalation. There was a significant decrease in VAS score (PϽ0.05) during inhalation of 20% nitrous oxide whereas there were no changes in VAS scores during inhalation of 20% nitrogen.
Seven of nine subjects reported that they noted a clear difference in subjective experiences between the two trials. They felt slight sedation or feelings of relaxation and euphoria occasionally during one of the two trials.
Discussion
We have found that a low concentration of nitrous oxide relieved dyspnoea during severe respiratory loading. There are several possible explanations.
First, the reduction of dyspnoea could be caused by a reduction in ventilatory drive during inhalation of nitrous oxide. An increase in inspiratory motor output or respiratory drive causes an increased sense of effort and dyspnoea. 4 In our studies, there was no significant decrease in minute ventilation, VT/TI or Pmax during inhalation of nitrous oxide indicating that there is little, if any, change in respiratory drive, although there were considerable changes in breathing patterns characterized by a decrease in f and an increase in VT. The results of previous studies 5 6 showed that a low concentration (20%) of nitrous oxide did not affect minute ventilation. Furthermore, hypercapnic and hypoxic responses are not affected by low concentrations of nitrous oxide. 6 Therefore, it is unlikely that the decrease in ventilatory drive was responsible for the decrease in dyspnoea during nitrous oxide inhalation.
Breathing may be partly behaviourally controlled in an effort to minimize the sensation of respiratory discomfort. 7 In this context, changes in breathing patterns might be associated with altered behavioural responses, such as Effect of nitrous oxide on dyspnoea impaired psychomotor function, cognitive performance, and learning and memory processes during inhalation of nitrous oxide. 8 However, it is also possible that the observed changes in breathing patterns might be the result of alleviation of anxiety caused by nitrous oxide.
Our results support those of Fothergill and Carlson 9 who showed that inhalation of 23% nitrous oxide reduced the perception of respiratory effort without altering the respiratory load compensation mechanism. In contrast with our observations, they reported that inhalation of nitrous oxide increased respiratory frequency with no change in tidal volume. However, comparison of their results and ours may be difficult as their study was performed during strenuous exercise with an inspiratory resistive loading, while our study was performed at rest with a combination of hypercapnia and elastic loading.
Second, slight sedation or feelings of relaxation are often noted at low concentrations of nitrous oxide, and euphoria occurs occasionally. Other senses, such as touch, hearing, vision and proprioception, are impaired by low concentrations of nitrous oxide and psychomotor activity is slightly affected. 10 11 Although the observed improvements in dyspnoea with nitrous oxide may be a result of a non-specific sedative effect, sedatives such as benzodiazepine derivatives have been reported to have no effect on dyspnoea. 12 13 Thus there may be other mechanisms involved, perhaps specific to nitrous oxide.
Third, there is a possibility that the reduction in dyspnoea during nitrous oxide inhalation might be caused by modulation of neural mechanisms subserving abnormal respiratory sensation. For example, opioid receptors are present in the thalamus, amygdala and frontal cortex, 14 and the increased endogenous opioids may activate the endogenous opioid mechanisms in these particular regions, which in turn may relieve dyspnoea. Nitrous oxide acts to release methinineenkephalin, β-endorphin and other opioid peptides. 15 16 In addition, the study of Gyulai and colleagues 8 showed that inhalation of 20% nitrous oxide was associated with significant activation in the anterior cingulate cortex, a limbic area known to be activated by morphine. 17 Finally, an effect of nitrous oxide on pulmonary vagal afferents, particularly those from pulmonary stretch receptors (PSR), might contribute to the relief of dyspnoea as there is some evidence to suggest that PSR play an important role in the relief of respiratory distress. 18 19 Whitteridge and Bulbring 20 showed in animal studies that nitrous oxide sensitized and increased the activity of PSR. Eldridge and Chen 21 proposed that the relief of respiratory distress results from expansion of the lungs and activation of PSR. Their hypothesis is based on the experimental results that vagal input, probably from PSR, tonically inhibits the respiratoryassociated firing of the mesencephalic neurones by a direct mechanism that is independent of a vagal effect on medullary respiratory drive. They suggested that midbrain neurones are involved in transmitting respiratory-related information to still higher levels of the brain, where the 18 information may ultimately be interpreted as dyspnoea or respiratory distress.
In summary, our results indicated that a low concentration of nitrous oxide reduced dyspnoea without impairing respiratory load compensation.
